The Enterprise Value as of November 2024 (TTM) for Bavarian Nordic A/S (BVNKF) is 14.95B

According to Bavarian Nordic A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 14.95B. This represents a change of 71.48% compared to the average of 8.72B of the last 4 quarters.

Bavarian Nordic A/S (BVNKF) Historical Enterprise Value (quarterly & annually)

How has BVNKF Enterprise Value performed in the past?

The mean historical Enterprise Value of Bavarian Nordic A/S over the last ten years is 10.63B. The current 14.95B Enterprise Value has changed 13.97% with respect to the historical average. Over the past ten years (40 quarters), BVNKF's Enterprise Value was at its highest in in the September 2021 quarter at 22.68B. The Enterprise Value was at its lowest in in the September 2024 quarter at -882391000.00.

Bavarian Nordic A/S (BVNKF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bavarian Nordic A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bavarian Nordic A/S (BVNKF) Average Enterprise Value

How has BVNKF Enterprise Value performed in the past?

The current Enterprise Value of Bavarian Nordic A/S (BVNKF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bavarian Nordic A/S (BVNKF) Enterprise Value vs. Peers

How is BVNKF’s Enterprise Value compared to its peers?

Bavarian Nordic A/S’s Enterprise Value is greater than AN2 Therapeutics, Inc. (6.48M), greater than Miromatrix Medical Inc. (90.06M), greater than Inhibikase Therapeutics, Inc. (154.45M), greater than PMV Pharmaceuticals, Inc. (47.77M), greater than Anebulo Pharmaceuticals, Inc. (36.46M), greater than Molecular Partners AG (132.68M), greater than Mineralys Therapeutics, Inc. (523.81M), greater than Pharvaris N.V. (850.00M), greater than PepGen Inc. (120.50M), greater than Edgewise Therapeutics, Inc. (3.01B), greater than Rallybio Corporation (17.23M), greater than Opthea Limited (514.42M), greater than Replimune Group, Inc. (984.10M), greater than Nuvalent, Inc. (6.38B), greater than Ventyx Biosciences, Inc. (80.09M), greater than Ascendis Pharma A/S (7.61B), less than United Therapeutics Corporation (15.49B), greater than Aura Biosciences, Inc. (437.65M), greater than Axcella Health Inc. (-14986000.00), greater than H-CYTE, Inc. (8.16M), greater than Antibe Therapeutics Inc. (4.67M),

Build a custom stock screener for Bavarian Nordic A/S (BVNKF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bavarian Nordic A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bavarian Nordic A/S (BVNKF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bavarian Nordic A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.